Profile data is unavailable for this security.
About the company
Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)’s drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.
- Revenue in SEK (TTM)22.65m
- Net income in SEK-47.51m
- Incorporated2004
- Employees19.00
- LocationNanologica AB (publ)Forskargatan 20 GSODERTALJE 151 36SwedenSWE
- Phone+46 841074949
- Websitehttps://www.nanologica.com/
More ▼
Mergers & acquisitions
| Acquired company | NICA:STO since announced | Transaction value |
|---|---|---|
| Ardena Sodertalje AB | -29.12% | 974.00k |
Data delayed at least 15 minutes, as of Feb 10 2026 09:34 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tribox Group AB | 127.22m | -2.33m | 30.54m | 17.00 | -- | 1.25 | 5.94 | 0.2401 | -0.0135 | -0.0135 | 0.7306 | 0.1388 | 2.18 | 5.11 | 10.26 | 7,950,938.00 | -3.99 | -39.00 | -8.62 | -74.20 | 25.34 | 20.92 | -1.83 | -31.22 | 0.7193 | 0.0129 | 0.3565 | -- | 76.92 | 196.63 | 30.18 | -- | 10.42 | -- |
| Prebona AB | 3.44m | -7.08m | 34.40m | -- | -- | 17.66 | -- | 10.00 | -0.2273 | -0.2273 | 0.1115 | 0.0572 | 0.1948 | -0.2126 | 1.36 | -- | -40.09 | -42.26 | -57.56 | -63.33 | 109.05 | 117.51 | -205.80 | -124.05 | 0.8893 | -6.75 | 0.7692 | -- | -33.09 | 24.07 | -20.84 | -- | 9.95 | -- |
| Nanologica AB (publ) | 22.65m | -47.51m | 35.34m | 19.00 | -- | 0.8738 | -- | 1.56 | -0.5928 | -0.5928 | 0.2739 | 0.4578 | 0.2306 | 0.7063 | 12.61 | 1,415,313.00 | -48.39 | -45.84 | -154.29 | -55.48 | 21.95 | 58.74 | -209.82 | -564.66 | 1.53 | -11.99 | 0.3277 | -- | 907.48 | 9.52 | 12.68 | -- | -52.52 | -- |
| CirChem AB | 14.20m | -6.86m | 40.21m | 12.00 | -- | 0.8197 | -- | 2.83 | -0.1865 | -0.1865 | 0.4106 | 1.22 | 0.219 | 13.08 | 3.73 | 1,183,417.00 | -10.58 | -25.26 | -13.34 | -35.19 | 53.58 | -89.86 | -48.31 | -252.53 | 1.91 | -8.22 | 0.1531 | -- | 259.61 | 305.81 | 93.75 | -- | -12.32 | -- |
| Svenska Aerogel Holding AB (publ) | 4.54m | -32.01m | 46.21m | 15.00 | -- | 1.01 | -- | 10.19 | -2.29 | -2.29 | 0.2752 | 1.57 | 0.0856 | 8.03 | 7.30 | 302,333.30 | -60.39 | -51.60 | -71.49 | -69.35 | -230.61 | 77.19 | -705.80 | -1,348.45 | 2.58 | -73.09 | 0.015 | -- | -16.92 | 40.01 | 22.37 | -- | -64.85 | -- |
| aXichem AB (publ) | 15.99m | -17.67m | 81.58m | 7.00 | -- | 1.41 | -- | 5.10 | -0.3116 | -0.3116 | 0.2792 | 0.9819 | 0.239 | 1.94 | 2.60 | 2,284,857.00 | -26.41 | -27.35 | -30.25 | -31.60 | -12.26 | -103.23 | -110.50 | -402.81 | 1.05 | -36.22 | 0.0386 | -- | 373.74 | 90.34 | 14.41 | -- | 11.20 | -- |
| Bergen Carbon Solutions AS | 0.00 | -42.42m | 151.70m | 25.00 | -- | 1.08 | -- | -- | -1.08 | -1.08 | 0.00 | 3.59 | 0.00 | 0.2542 | -- | 0.00 | -23.61 | -23.81 | -24.77 | -24.96 | -- | -350.10 | -- | -21,396.38 | 17.71 | -- | 0.0763 | -- | -- | -- | 1.22 | -- | 6.59 | -- |
Data as of Feb 10 2026. Currency figures normalised to Nanologica AB (publ)'s reporting currency: Swedish Krona SEK
0.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Handelsbanken Fonder ABas of 31 Dec 2025 | 560.51k | 0.63% |
| Swedbank Robur Fonder ABas of 30 Dec 2025 | 252.68k | 0.29% |
| SEB Funds ABas of 31 Dec 2025 | 53.33k | 0.06% |
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
